Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/µl is associated with improved treatment outcomes in South Africa
| dc.contributor.author | Zeinecker, Jennifer | |
| dc.contributor.author | Orrell, Catherine | |
| dc.contributor.author | Wood, Robin | |
| dc.date.accessioned | 2016-07-29T12:10:26Z | |
| dc.date.available | 2016-07-29T12:10:26Z | |
| dc.date.issued | 2010 | |
| dc.date.updated | 2016-06-09T10:54:15Z | |
| dc.description.abstract | Observational cohort study. Methods Patients presenting to primary care clinics with CD4 cell counts <350 cells/mm3 were randomized to either doctor- or nurse-managed HIV care and followed for at least two years after ART initiation. Clinical and laboratory outcomes were compared by baseline CD4 count. Results 812 patients were followed for a median of 27.5 months and 36% initiated with a CD4 count >200. While 10% of patients failed virologically (VF), the risk was nearly double among those with a CD4 ≤200 vs. >200 (12.2% vs. 6.8%). 21 deaths occurred, with a five-fold increased risk for the low CD4 group (3.7% vs. 0.7%). After adjustment, those with a CD4 count ≤200 had twice the risk of death/VF (HR 1.9; 95% CI: 1.1–3.3) and twice the risk of incident tuberculosis (HR: 1.90; 95% CI: 0.89–4.04) as those >200. Those with either a CD4 ≤200 (HR 2.1; 1.2–3.8) or a WHO IV condition (HR 2.9; 0.93–8.8) alone had a two to three-fold increased risk of death/VF vs. those with neither, but those with both conditions had a 4-fold increased risk (HR 3.9; 95% CI: 1.9–8.1). We observed some increased loss to follow-up among those initiating <200 (HR 0.79; 95% CI: 0.50–1.25). Conclusions Patients initiating ART with higher CD4 counts had reduced mortality, tuberculosis and less virologic failure than those initiated at lower CD4 counts. Our data support increasing CD4 count eligibility criteria for ART initiation. | |
| dc.identifier | http://dx.doi.org/10.1097/QAD.0b013e32833c703e | |
| dc.identifier.apacitation | Zeinecker, J., Orrell, C., & Wood, R. (2010). Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/µl is associated with improved treatment outcomes in South Africa. <i>AIDS</i>, http://hdl.handle.net/11427/21030 | en_ZA |
| dc.identifier.chicagocitation | Zeinecker, Jennifer, Catherine Orrell, and Robin Wood "Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/µl is associated with improved treatment outcomes in South Africa." <i>AIDS</i> (2010) http://hdl.handle.net/11427/21030 | en_ZA |
| dc.identifier.citation | Fox, M. P., Sanne, I. M., Conradie, F., Zeinecker, J., Orrell, C., Ive, P., ... & Wood, R. (2010). Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa. AIDS (London, England), 24(13), 2041-2050. | |
| dc.identifier.issn | 0269-9370 | |
| dc.identifier.ris | TY - Journal Article AU - Zeinecker, Jennifer AU - Orrell, Catherine AU - Wood, Robin AB - Observational cohort study. Methods Patients presenting to primary care clinics with CD4 cell counts <350 cells/mm3 were randomized to either doctor- or nurse-managed HIV care and followed for at least two years after ART initiation. Clinical and laboratory outcomes were compared by baseline CD4 count. Results 812 patients were followed for a median of 27.5 months and 36% initiated with a CD4 count >200. While 10% of patients failed virologically (VF), the risk was nearly double among those with a CD4 ≤200 vs. >200 (12.2% vs. 6.8%). 21 deaths occurred, with a five-fold increased risk for the low CD4 group (3.7% vs. 0.7%). After adjustment, those with a CD4 count ≤200 had twice the risk of death/VF (HR 1.9; 95% CI: 1.1–3.3) and twice the risk of incident tuberculosis (HR: 1.90; 95% CI: 0.89–4.04) as those >200. Those with either a CD4 ≤200 (HR 2.1; 1.2–3.8) or a WHO IV condition (HR 2.9; 0.93–8.8) alone had a two to three-fold increased risk of death/VF vs. those with neither, but those with both conditions had a 4-fold increased risk (HR 3.9; 95% CI: 1.9–8.1). We observed some increased loss to follow-up among those initiating <200 (HR 0.79; 95% CI: 0.50–1.25). Conclusions Patients initiating ART with higher CD4 counts had reduced mortality, tuberculosis and less virologic failure than those initiated at lower CD4 counts. Our data support increasing CD4 count eligibility criteria for ART initiation. DA - 2010 DB - OpenUCT DP - University of Cape Town J1 - AIDS KW - Human Immunodeficiency Virus KW - Sub-Saharan Africa KW - Highly Active Antiretroviral Therapy KW - CD4 count KW - Mortality KW - Virologic Failure KW - Tuberculosis LK - https://open.uct.ac.za PB - University of Cape Town PY - 2010 SM - 0269-9370 T1 - Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/µl is associated with improved treatment outcomes in South Africa TI - Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/µl is associated with improved treatment outcomes in South Africa UR - http://hdl.handle.net/11427/21030 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/21030 | |
| dc.identifier.uri | http://europepmc.org/articles/pmc2914833 | |
| dc.identifier.vancouvercitation | Zeinecker J, Orrell C, Wood R. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/µl is associated with improved treatment outcomes in South Africa. AIDS. 2010; http://hdl.handle.net/11427/21030. | en_ZA |
| dc.language.iso | eng | |
| dc.publisher | Wolters Kluwer Health | |
| dc.publisher.department | Department of Medicine | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.source | AIDS | |
| dc.source.uri | http://journals.lww.com/aidsonline/pages/default.aspx | |
| dc.subject | Human Immunodeficiency Virus | |
| dc.subject | Sub-Saharan Africa | |
| dc.subject | Highly Active Antiretroviral Therapy | |
| dc.subject | CD4 count | |
| dc.subject | Mortality | |
| dc.subject | Virologic Failure | |
| dc.subject | Tuberculosis | |
| dc.title | Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/µl is associated with improved treatment outcomes in South Africa | |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |